Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
$4.37−0.04 (-0.79%)
Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –
Alvotech operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was 13.3%, against 14.2% the year before. The highest annual figure on record is 14.2% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.3% | −0.9 |
| FY2024 | Dec 31, 2024 | 14.2% | +402.3 |
| FY2023 | Dec 31, 2023 | -388.1% | +29.1 |
| FY2022 | Dec 31, 2022 | -417.3% | +223.1 |
| FY2021 | Dec 31, 2021 | -640.3% | −433.9 |
| FY2020 | Dec 31, 2020 | -206.5% | – |
See a number that looks wrong?